Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Self · Edwards Lifesciences Corp · Edwards Lifesciences Corporation Common Stock
Purchase
Disclosed range starting at $1K
Disclosed 116 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Zovighian Bernard JDirector, CEO | Option exercise · 10b5-1 plan | M | $1.68M 23.1K sh | Nov 9, 2026 traded Nov 9, 2026 | |
| 20 | Zovighian Bernard JDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $949K 9,184 sh | Nov 9, 2026 traded Nov 9, 2026 | |
| 23 | Zovighian Bernard JDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $1.43M 13.9K sh | Nov 9, 2026 traded Nov 9, 2026 | |
| 0 | Zovighian Bernard JDirector, CEO | Option exercise · 10b5-1 plan | M | — 23.1K sh | Nov 9, 2026 traded Nov 9, 2026 | |
| 20 | Bobo Donald E JrCVP,Strategy/Corp Development | Option exercise · 10b5-1 plan | M | $3.55M 48.9K sh | Nov 9, 2026 traded Nov 9, 2026 | |
| 31 | Bobo Donald E JrCVP,Strategy/Corp Development | Open-market sale · 10b5-1 plan | SELL | $5.04M 48.9K sh | Nov 9, 2026 traded Nov 9, 2026 | |
| 0 | Bobo Donald E JrCVP,Strategy/Corp Development | Option exercise · 10b5-1 plan | M | — 48.9K sh | Nov 9, 2026 traded Nov 9, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Alan Armstrong reported a purchase of Edwards Lifesciences Corporation Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
Recorded votes from the House Clerk and Voteview (Senate). Listed by date; a vote near a trade is not evidence the two are related.